BIB icon

ProShares Ultra NASDAQ Biotechnology

41 hedge funds and large institutions have $24.1M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

17% less capital invested

Capital invested by funds: $29M → $24.1M (-$4.96M)

26% less call options, than puts

Call options by funds: $15.9M | Put options by funds: $21.6M

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$15.9M
Puts
$21.6M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.3M
2
$2.73M
3
$2.55M
4
$1.56M
5
$1.2M
6
$1M
7
$657K
8
$551K
9
$551K
10
$466K
11
$423K
12
$388K
13
$316K
14
$235K
15
$232K
16
$222K
17
$164K
18
$95K
19
$93K
20
$55K
21
$51K
22
$25K
23
$21K
24
$20K
25
$18K